Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Greenwich Lifesciences

GLSI

15.0305.47% ( -0.870 )

Closed: Sep 9, 16:00:00 (EDT)

OverviewOverview OptionsOptions NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

U.S. stock night market fluctuations: GLSI rose 10.23% in the night market with no significant positive news, attracting attention due to capital movement
Price Alert·Sep 1 at 01:21 AM
GLSI-5.47%
Greenwich LifeSciences (NASDAQ:GLSI) Posts Quarterly Earnings Results
Market Beat·Aug 11 at 10:41 PM
GLSI-5.47%BCS-1.34%
Greenwich LifeSciences extends insider lock-up to Jan. 31, 2027
PUBT·Aug 10 at 10:01 AM
GLSI-5.47%
Top Executive Doubles Down on Greenwich LifeSciences With Fresh Insider Buy
Tip Ranks·Jul 31 at 02:05 AM
GLSI-5.47%
Greenwich LifeSciences (NASDAQ:GLSI) CEO Snehal Patel Purchases 1,500 Shares
Market Beat·Jul 29 at 11:07 AM
- Greenwich LifeSciences CEO Snehal Patel purchased 1,500 shares of company stock at an average cost of $13.62 per share, totaling $20,430.00. - This transaction followed previous purchases made on July 23rd and July 24th, increasing his total holdings to 5,609,202 shares valued at $76,397,331.24. - The acquisition was officially disclosed in a regulatory filing with the Securities & Exchange Commission.
GLSI-5.47%BAC+0.45%
Greenwich Lifesciences CEO and CFO Snehal Patel acquires $20,430 of common shares
PUBT·Jul 29 at 10:08 AM
GLSI-5.47%
Greenwich LifeSciences CEO, CFO Snehal Patel acquires common shares worth $47,005
PUBT·Jul 27 at 10:15 AM
GLSI-5.47%
U.S. stock market midday update: Greenwich Lifesciences down 7.34%, clinical standards approved by the UK, analysts remain cautious
Price Alert·Jul 22 at 05:48 PM
GLSI-5.47%
Greenwich LifeSciences wins UK regulatory clearance to expand FLAMINGO-01 trial
PUBT·Jul 22 at 10:00 AM
GLSI-5.47%
HC Wainwright Forecasts Strong Price Appreciation for Greenwich LifeSciences (NASDAQ:GLSI) Stock
Market Beat·Jul 21 at 05:18 PM
GLSI-5.47%